Author:
Hemphill C. Scott,Sampat Bhaven N.
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference30 articles.
1. Authorized generic drugs, price competition and consumers’ welfare;Berndt;Health Affairs,2007
2. Berndt, E., Mortimer, R., Parece, A., 2007b. Do authorized generic drugs deter Paragraph IV certifications? Recent evidence. Unpublished working paper. Analysis Group, Cambridge, MA.
3. Branstetter, L., Chatterjee, C., Higgins, M., 2011. Regulation and welfare: evidence from Paragraph IV generic entry in the pharmaceutical industry. NBER working paper 17188.
4. Danzon, P., Furukawa, M., 2011. Cross-national evidence on generic pharmaceuticals: pharmacy vs. physician-driven markets. NBER working paper 17226.
5. National Formulary;Department of Veterans Affairs,2011
Cited by
134 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献